Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Cell Reports|April 14, 2021
Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtypeFátima Valdés-Mora, Robert Salomon, Brian Stewart Gloss, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 25, 2022
ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex VivoAndrew M K Law, Jiamin Chen, Yolanda Colino-Sanguino, et al.Nature Immunology|November 19, 2021
Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote TH2 and inhibit TH17 cell polarizationJohannes U Mayer, Kerry L Hilligan, Jodie S Chandler, et al.The Journal of Clinical Investigation|February 22, 2022
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironmentAngela M Araujo, Andrea Abaurrea, Peio Azcoaga, et al.Nature Communications|August 6, 2022
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasisMichael Papanicolaou, Amelia L Parker, Michelle Yam, et al.Scientific Data|June 23, 2023
DOCU-CLIM: A global documentary climate dataset for climate reconstructionsAngela-Maria Burgdorf, Stefan Brönnimann, George Adamson, et al.Plos Biology|January 10, 2013
ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancerMaria Kalyuga, David Gallego-Ortega, Heather J Lee, et al.Journal of Sport and Health Science|September 28, 2024
Decorin, an exercise-induced secretory protein, is associated with improved prognosis in breast cancer patients but does not mediate anti-tumorigenic tissue crosstalk in miceMarit Hjorth, Casey L Egan, Guilherme D Telles, et al.Plos Biology|December 31, 2015
ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor CellsDavid Gallego-Ortega, Anita Ledger, Daniel L Roden, et al.Nature Communications|May 11, 2026
Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signallingKristine J Fernandez, Ghazal Sultani, Max Nobis, et al.Pageof 9